blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2216404

EP2216404 - Method of producing an antibody using a cell in which the function of fucose transporter is inhibited [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  28.09.2012
Database last updated on 05.08.2024
Most recent event   Tooltip28.09.2012Application deemed to be withdrawnpublished on 31.10.2012  [2012/44]
Applicant(s)For all designated states
Chugai Seiyaku Kabushiki Kaisha
5-1, Ukima 5-chome Kita-ku
Tokyo 115-8543 / JP
[2010/32]
Inventor(s)01 / Tsuchiya, Masayuki
c/o Chugai Seiyaku Kabushiki Kaisha 135, Komakado 1-chome
Gotenba-shi Shizuoka 412-8513 / JP
02 / Iijima, Shigeyuki
c/o Chugai Seiyaku Kabushiki Kaisha 135, Komakado 1-chome
Gotenba-shi Shizuoka 412-8513 / JP
03 / Sugo, Izumi
c/o Chugai Seiyaku Kabushiki Kaisha 135, Komakado 1-chome
Gotenba-shi Shizuoka 412-8513 / JP
04 / Sekimori, Yasuo
c/o Chugai Seiyaku Kabushiki Kaisha 135, Komakado 1-chome
Gotenba-shi Shizuoka 412-8513 / JP
05 / Habu, Kiyoshi
c/o Chugai Seiyaku Kabushiki Kaisha 135, Komakado 1-chome
Gotenba-shi Shizuoka 412-8513 / JP
06 / Sugimoto, Masamichi
c/o Chugai Seiyaku Kabushiki Kaisha 200, Kajiwara
Kamakura-shi Kanagawa 247-8530 / JP
 [2010/32]
Representative(s)Dempster, Robert Charles
D Young & Co LLP
120 Holborn
London EC1N 2DY / GB
[N/P]
Former [2010/32]Dempster, Robert Charles
D Young & Co LLP 120 Holborn
London EC1N 2DY / GB
Application number, filing date10162932.726.10.2005
[2010/32]
Priority number, dateWO2004JP1926122.12.2004         Original published format: PCT/JP2004/019261
[2010/32]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP2216404
Date:11.08.2010
Language:EN
[2010/32]
Search report(s)(Supplementary) European search report - dispatched on:EP12.07.2010
ClassificationIPC:C12N15/00, A01H5/00, A01K67/027, A61K39/395, A61P9/00, A61P29/00, A61P31/04, A61P31/12, A61P35/00, A61P37/00, A61P37/08
[2010/32]
CPC:
C12N9/1081 (EP,US); A61P29/00 (EP); A61P31/04 (EP);
A61P31/12 (EP); A61P35/00 (EP); A61P37/00 (EP);
A61P37/08 (EP); A61P9/00 (EP); C07K16/00 (EP,US);
A01K2217/075 (EP,US); A01K2227/10 (EP,US); C07K2317/41 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2010/32]
TitleGerman:Verfahren zur Herstellung eines Antikörpers durch Verwendung einer Zelle mit gehemmter Fucosetransporterfunktion[2010/32]
English:Method of producing an antibody using a cell in which the function of fucose transporter is inhibited[2010/32]
French:Procédé de préparation d'anticorps basé sur l'utilisation d'une cellule dont la fonction de transporteur du fucose est inhibée[2010/32]
Examination procedure08.02.2011Amendment by applicant (claims and/or description)
08.02.2011Examination requested  [2011/11]
31.03.2011Despatch of a communication from the examining division (Time limit: M06)
06.10.2011Reply to a communication from the examining division
03.01.2012Despatch of a communication from the examining division (Time limit: M04)
15.05.2012Application deemed to be withdrawn, date of legal effect  [2012/44]
15.06.2012Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2012/44]
Parent application(s)   TooltipEP05800043.1  / EP1829962
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued (EP20050800043) is  13.08.2008
Fees paidRenewal fee
07.06.2010Renewal fee patent year 03
07.06.2010Renewal fee patent year 04
07.06.2010Renewal fee patent year 05
27.10.2010Renewal fee patent year 06
26.10.2011Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[Y]US2004110282  (KANDA YUTAKA [JP], et al) [Y] 1-4 * figure 2 *;
 [Y]  - YAMANE-OHNUKI N ET AL, "Establishment of FUT8 knockout chinese hanster ovary cells: an ideal host cell line for producing completely defucosylated antibodies with enhanced antibody-dependent cellular cytotoxicity", BIOTECHNOLOGY AND BIOENGINEERING, WILEY & SONS, HOBOKEN, NJ, US LNKD- DOI:10.1002/BIT.20151, (20040806), vol. 87, no. 5, ISSN 0006-3592, pages 614 - 622, XP002983758 [Y] 1-4 * the whole document *

DOI:   http://dx.doi.org/10.1002/bit.20151
 [A]  - MORTENSEN R M ET AL, Inactivation of G-protein genes: double knockout in cell lines, METHODS IN ENZYMOLOGY; HETEROTRIMERIC G PROTEINS; [METHODS IN ENZYMOLOGY], ACADEMIC PRESS INC, SAN DIEGO, CA, US LNKD- DOI:10.1016/S0076-6879(94)37075-3, PAGE(S) 356 - 366, (19940101), ISSN 0076-6879, XP008115526 [A] 1-4 *Introduction*

DOI:   http://dx.doi.org/10.1016/S0076-6879(94)37075-3
by applicantEP0239400
 JPH0159878B
 EP0404097
 WO9201047
 WO9203918
 WO9220791
 WO9306213
 WO9311236
 WO9311161
 WO9312227
 WO9319172
 WO9402602
 WO9425585
 WO9501438
 WO9515388
 WO9602576
 WO9634096
 WO9633735
 WO9846777
 JPH11503015
 WO0061739
 WO0233054
 WO2005014651
    - SHIELDS ET AL., J BIOL CHEM, (2002), vol. 277, no. 30, pages 26733 - 26740
    - PATE L. SMITH ET AL., J. CELL BIOL., (2002), vol. 158, pages 801 - 815
    - SATO, K. ET AL., CANCER RES, (1993), vol. 53, pages 851 - 856
    - HUSTON, J. S. ET AL., PROC. NATI ACAD. SCI. U.S.A., (1988), vol. 85, pages 5879 - 5883
    - CO, M. S. ET AL., J. IMMUNOL., (1994), vol. 152, pages 2968 - 2976
    - BETTER, M; HORWITZ, A H., METHODS ENZYMOL., (1989), vol. 178, pages 476 - 496
    - PLUCKTHUN, A.; SKERRA, A., METHODS ENZYMOL., (1989), vol. 178, pages 497 - 515
    - LAMOYI, E., METHODS ENZYMOL., (1986), vol. 121, pages 652 - 663
    - ROUSSEAUX, J. ET AL., METHODS ENZYMOL., (1986), vol. 121, pages 663 - 669
    - BIRD, R. E.; WALKER, B. W., TRENDS BIOTECHNOL., (1991), vol. 9, pages 132 - 137
    - P. HOLLIGER ET AL., PIOC NATL. ACAD. SCI. U.S.A., (1993), vol. 90, pages 6444 - 6448
    - JOHNSON ET AL., METHODS IN ENZYMOLOGY, (1991), vol. 203, pages 88 - 98
    - HOLLIGER ET AL., PROTEIN ENGINEERING, (1996), vol. 9, pages 299 - 305
    - PERISIC ET AL., STRUCTURE, (1994), vol. 2, pages 1217 - 1226
    - JOHN ET AL., PROTEIN ENGINEERING, (1999), vol. 12, no. 7, pages 597 - 604
    - HOLLIGER ET AL., PROC. NATL. ACAD. SCI. U.S.A., (1993), vol. 90, pages 6444 - 6448
    - ATWELL ET AL., MOL. IMMUNOL., (1996), vol. 33, pages 1301 - 1312
    - J. EXP. MED., (1995), vol. 108, page 945
    - VALLE ET AL., NATURE, (1981), vol. 291, pages 358 - 340
    - PROC NATL. ACAD. SCI.. U.S.A, (1980), vol. 77, pages 4216 - 4220
    - PROC. NAT1. ACAD. SCI. U.S.A., (1968), vol. 60, page 1275
    - NUCLEIC ACIDS. RES., (1990), vol. 18, no. 17, page 5322
    - MULLIGAN ET AL., NATURE, (1979), vol. 277, page 108
    - MIZUSHIMA ET AL., NUCLEIC ACIDS RES., (1990), vol. 18, page 5322
    - EBERT, K.M. ET AL., BIO/TECHNOLOGY, (1994), vol. 12, pages 699 - 702
    - KOHLER, G; MILSTEIN, C., METHODS ENZYMOL., (1981), vol. 73, pages 3 - 46
    - ANAL. BIOCHEM, (1988), vol. 171, page 73
    - YAGI T, PROC. NATL. ACAD.. SCI. USA, (1990), vol. 87, pages 9918 - 9922
    - POPO H, BIOCHEMICAL GENETICS, (1990), vol. 28, pages 299 - 308
    - WEITZHANDLER M ET AL., TOURNAL OF PHARMACEUTICAL SCIENCES, (1994), vol. 83, no. 12, pages 1670 - 1675
    - SCHENK B ET AL., THE JOURNAL OF CLINICAL INVESTIGATION, (2001), vol. 108, no. 11, pages 1687 - 1695
    - BIGGE J C. ET AL., ANALYTICAL BIOCHEMISTRY, (1995), vol. 230, no. 2, pages 229 - 238
    - WEITZHANDLER M. ET AL., JOURNAL OF PHARMACEUTICAL SCIENCES, (1994), vol. 83, no. 12, pages 1670 - 1675
    - SCHENK B. ET AL., THE JOURNAL OF CLINICAL INVESTIGATION, (2001), vol. 108, no. 11, pages 1687 - 1695
    - BIGGE J, C. ET AL., ANALYTICAL BIOCHEMISTRY, (1995), vol. 230, no. 2, pages 229 - 238
    - HIRATA ET AL., FEBS LETTER, (1994), vol. 356, pages 244 - 248
    - NIWA ET AL., GENE, (1991), vol. 108, pages 193 - 199
    - NIWA ET AL., GENE, (1991), vol. 108, pages 193 - 200
    - SMITHSON ET AL., MOL IRNNRUNOL., (1999), vol. 36, pages H3 - I24
    - SATO ET AL., MOL LMMUNOL., (1994), pages 371 - 381
    - ROCINSON ET AL., PROC. NATL. ACAD- SCI. U S A., (2001), vol. 98, pages 944 - 949
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.